Nifty valuations have reverted close to their pre-Covid average after the recent correction, prompting Jefferies to argue that valuations are now turning attractive and to tweak its India model portfolio in favour of banks, pharma and real estate while trimming exposure to autos, cement and BPCL. The brokerage notes that the Nifty 12‑month forward price-to-earnings […]
Ola electric share price: Ola Electric shares surge 17% in two days on strong March performance; daily orders exceed 1,000 units
Ola Electric share price: The shares of Ola Electric Mobility jumped around 17% in two days despite overall market weakness on Thursday after the EV scooter maker posted strong March sales data that boosted investor sentiment for the stock. Ola Electric on Wednesday reported a “strong comeback in business performance”, with daily orders exceeding 1,000 […]
Karnataka Bank shares tumble 6% after lender’s Q4 deposits rise 4%, advances up 7%
The shares of Karnataka Bank dropped nearly 6% on Thursday after the lender released a provisional business update for the January-March quarter of the financial year 2026 (Q4 FY26). The bank on Wednesday reported CASA (current account-savings account) deposits at Rs 36,621 crore for the fourth quarter of FY26. This marks a 10% YoY rise […]
More missiles or no war? How markets are reading Trump’s latest signals
Indian markets nosedived Thursday after US President Donald Trump threatened escalating strikes on Iran in a prime-time address that spooked investors who had been betting on a fast end to the conflict, with the Sensex tumbling around 1,400 points and the Nifty dropping roughly 2%. The selloff rippled across emerging Asia, where equities and currencies […]
Tariff threat ain’t over yet! Sun Pharma, other pharma stocks plunge up to 6%
Shares of Sun Pharma, Dr Reddy’s, Divis Laboratories, Cipla, Glenmark, among others, tumbled up to 6% on Thursday after a news report by Bloomberg reported that the US President Donald Trump administration is set to announce tariffs as soon as Thursday on drugmakers that have not struck deals guaranteeing low prices in the country. The […]
Will FY27 be better than ‘black swan’ FY26 for markets? Here’s what Motilal Oswal says
Indian stock markets saw a sharp decline in the financial year 2026, underperforming global peers. However, the near “black swan” FY26 has now set a strong base for FY27, which began on April 1, according to Motilal Oswal Financial Services. The domestic brokerage noted that FY26 was a near six-sigma year, marked by major geo-economic […]
Nifty’s December bull case target at 29,480, says Axis Direct; names 15 stocks to ride Iran war-driven volatility
Domestic brokerage Axis Direct has set the Nifty target for December 2026 at 29,480, implying a 30% upside from current levels. Indian equities underperformed the US and other emerging markets by a significant margin in 2025, resulting in a meaningful moderation in valuations. The FTSE India index is now trading at a price-to-earnings premium of […]
9 smallcap stocks deliver 20%+ gains in two straight quarters, soar up to 95% in 6 months
9 smallcap stocks deliver 20%+ gains in two straight quarters, soar up to 95% in 6 months Source link
Sun Pharma most exposed Indian company to Trump’s new tariff threat, warns Jefferies
Sun Pharmaceutical Industries is the most exposed Indian drug maker to US President Donald Trump’s latest tariff threat on medicines, global brokerage Jefferies has warned, even as it reiterated that the base case remains for generic drugs to stay exempt from the proposed levy. Jefferies said media reports suggest the Trump administration is preparing to […]
PNB Q4 updates: Global business rises 11% YoY to Rs 29.72 lakh crore; advances jump 13%
State-lender Punjab National Bank (PNB) on Thursday announced an 11% growth in its global business for the quarter ending March at Rs 29.72 lakh crore compared to Rs 26.83 lakh crore in the year ago period. In this, the domestic business rose nearly 10% in Q4FY26 to Rs 28.45 lakh crore versus Rs 25.77 lakh […]